Obesity is a risk factor for transformed migraine but not chronic tension-type headache

Neurology

Volumn 67, Issue 2, 2006, Pages 252-257

  Bigal, Marcelo E ^a,b,c   Lipton, Richard B ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

^c NEW ENGLAND CENTER FOR HEADACHE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHRONIC DAILY HEADACHE; CHRONIC TENSION HEADACHE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEADACHE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; PRIORITY JOURNAL; RISK; RISK FACTOR; TRANSFORMED MIGRAINE; UNDERWEIGHT; ADOLESCENT; CHRONIC DISEASE; COMORBIDITY; DISABILITY; HOSPITALIZATION; METHODOLOGY; MIDDLE AGED; RISK ASSESSMENT; TENSION HEADACHE; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TENSION-TYPE HEADACHE; UNITED STATES;

EID: 33747032034     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000225052.35019.f9     Document Type: Article

References (28)

1. National Center for Chronic Disease Prevention and Health Promotion. Overweight and obesity: obesity trends. Available at: http://www.cdc.gov/ nccdphp/dnpa/obesity/trend/maps/index.htm. Accessed 12/10/2005.
2. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
3. Scher AI, Stewart WF, Ricci JA, Lipton RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-89.
4. Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 1996;47:871-875.
5. Spierings ELH, Ranke AH, Schroevers M, Honkoop PC. Chronic daily headache: a time perspective. Headache 2000;40:306-310.
6. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62:788-790.
7. Bigal M, Liberman J, Lipton RB. Migraine and obesity. A population study. Neurology 2006;66:545-550.
8. Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology 1996;47:52-59.
9. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2004;24:1-160.
10. Bigal ME, Tepper SJ, Sheftell FD, Rapoport AM, Lipton RB. Chronic daily headache: correlation between the 2004 and the 1988 International Headache Society diagnostic criteria. Headache 2004;44:684-691.
11. Burstein R, Jakubowski M. Analgesic triptan action in an animal model of intracranial pain: a race against the development of central sensitization. Ann Neurol 2004;55:27-36.
12. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-624.
13. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002;161:233-242.
14. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-417.
15. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005;5:70-75.
16. Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I. Adipose tissue and atherothrombosis. Pathophysiol Haemost Thromb 2004;33:290-297.
17. Reuter U, Bolay H, Jansen-Olesen I, et al. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain 2001;124:2490-2502.
18. Goadsby PJ. Migraine pathophysiology. Headache 2005;45(suppl 1):S14-S24.
19. Welch KM. Contemporary concepts of migraine pathogenesis. Neurology 2003;61:S2-S8.
20. Zelissen PM, Koppeschaar HP, Lips CJ, Hackeng WH. Calcitonin generelated peptide in human obesity. Peptides 1991;12:861-863.
21. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004;142:1171-1181.
22. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 2005;77:202-213.
23. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 2005 Dec;315:1380-1385.
24. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004;109:367-378.
25. Baranowska B, Wolinska-Witort E Martynska M, Chmielowska M, Baranowska-Bik A. Plasma orexin A, orexin B, leptin, neuropeptide Y (NPY) and insulin in obese women. Neuro Endocrinol Lett 2005;26:293-296.
26. Himes JH, Hannan P, Wall M, Neumark-Sztainer D. Factors associated with errors in self-reports of stature, weight, and body mass index in Minnesota adolescents. Ann Epidemiol 2005;15:272-278.
27. Schoenborn CA, Adams PF, Barnes PM. Body weight status of adults: United States, 1997-98. Adv Data 2002;330:1-15.
28. Luder E, Ehrlich RI, Lou WY, Melnik TA, Kattan M. Body mass index and the risk of asthma in adults. Respir Med 2004;98:29-37.